Massachusetts Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Buy
6,297
+55
+0.9% +$19.6K 0.96% 42
2025
Q4
$2.04M Sell
6,242
-7
-0.1% -$2.22K 0.95% 44
2025
Q3
$1.76M Sell
6,249
-269
-4% -$78K 0.88% 50
2025
Q2
$1.82M Buy
+6,518
New +$1.85M 1.03% 40
2025
Q1
Sell
-7,043
Closed -$1.84M 85
2024
Q4
$1.84M Sell
7,043
-25
-0.4% -$7.42K 1.13% 41
2024
Q3
$2.28M Sell
7,068
-141
-2% -$46.1K 1.44% 27
2024
Q2
$2.25M Buy
7,209
+25
+0.3% +$7.34K 1.51% 20
2024
Q1
$2.04M Sell
7,184
-25
-0.3% -$7.32K 1.44% 24
2023
Q4
$2.08M Buy
7,209
+67
+0.9% +$18.3K 1.68% 16
2023
Q3
$1.92M Sell
7,142
-100
-1% -$25K 1.76% 16
2023
Q2
$1.61M Sell
7,242
-25
-0.3% -$5.8K 1.54% 20
2023
Q1
$1.76M Sell
7,267
-625
-8% -$153K 1.81% 17
2022
Q4
$1.99M Buy
+7,892
New +$2.12M 1.92% 16

Other funds holding AMGN

Massachusetts Wealth Management's AMGN Position: Q1 2026 in Review

Massachusetts Wealth Management increased its Amgen (AMGN) stake by 0.88% in Q1 2026, buying an estimated $19.6K and bringing the position to 6,297 shares worth $2.22M. The position accounts for 0.96% of the portfolio, ranked #42.

Massachusetts Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $2.28M in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Massachusetts Wealth Management held 6,297 shares of Amgen worth $2.22M as of Q1 2026.
  • Massachusetts Wealth Management bought 55 Amgen shares in Q1 2026, an estimated $19.6K.
  • Amgen made up 0.96% of Massachusetts Wealth Management's portfolio in Q1 2026, its #42 holding.
  • Massachusetts Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
  • Massachusetts Wealth Management's Amgen position peaked at $2.28M in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Massachusetts Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.